Cargando…

Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer

BACKGROUND: Interactions between the programmed cell death receptor 1 (PD-1) and its ligand (PD-L1) lead to immune evasion in various tumors and are associated with poor prognosis in patients with pancreatic cancer; however, the roles of PD-L1-containing exosomes in pancreatic cancer is poorly under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Se Jun, Park, Ju Yeon, Shin, Kabsoo, Hong, Tae Ho, Lee, MyungAh, Kim, Younghoon, Kim, In-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150468/ https://www.ncbi.nlm.nih.gov/pubmed/37127565 http://dx.doi.org/10.1186/s12885-023-10811-8

Ejemplares similares

Histologic subtype-based evaluation of recurrence and survival outcomes in patients with adenocarcinoma of the ampulla of Vater
por: Park, Se Jun, et al.
Publicado: (2023)

Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
por: Park, Sejun, et al.
Publicado: (2023)

Oral chemotherapy for second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer
por: Park, Se Jun, et al.
Publicado: (2019)

Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

Case 2: A 66-Year-Old Man With Chronic Watery Diarrhea
por: Shin, Ji Eun, et al.
Publicado: (2022)

Early Increase in Circulating PD-1(+)CD8(+) T Cells Predicts Favorable Survival in Patients with Advanced Gastric Cancer Receiving Chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy
por: Shin, Kabsoo, et al.
Publicado: (2021)

Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer
por: Park, Se Jun, et al.
Publicado: (2021)

Nanoliposomal irinotecan plus fluorouracil and folinic acid as a second-line treatment option in patients with metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
por: Park, Se Jun, et al.
Publicado: (2021)

Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD‐L1
por: Shin, Jung Min, et al.
Publicado: (2021)

Clinical relevance of serum-derived exosomal messenger RNA sequencing in patients with non-Hodgkin lymphoma
por: Bang, Yeong Hak, et al.
Publicado: (2022)

Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study
por: Kim, In-Ho, et al.
Publicado: (2021)

Clinical Significance of CLDN18.2 Expression in Metastatic Diffuse-Type Gastric Cancer
por: Kim, Seo Ree, et al.
Publicado: (2020)

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
por: Li, Chuling, et al.
Publicado: (2019)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
por: Shin, Kabsoo, et al.
Publicado: (2019)

Clinical efficacy of serum lipase subtype analysis for the differential diagnosis of pancreatic and non-pancreatic lipase elevation
por: Bang, Chang Seok, et al.
Publicado: (2016)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer
por: Hyung, Sujin, et al.
Publicado: (2023)

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2014)

Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
por: Sohn, Won, et al.
Publicado: (2015)

The Correlation Between Serum Chemokines and Clinical Outcome in Patients with Advanced Biliary Tract Cancer
por: Lee, Su Jin, et al.
Publicado: (2018)

Survivin expression and its clinical significance in pancreatic cancer
por: Lee, Myung Ah, et al.
Publicado: (2005)

Clinical significance of urinary exosomal microRNAs in patients with IgA nephropathy
por: Yoon, Soo-Young, et al.
Publicado: (2023)

The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
por: Tang, Yanyan, et al.
Publicado: (2020)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma
por: Ryu, Kyung Ju, et al.
Publicado: (2020)

Advances in Analysis of Biodistribution of Exosomes by Molecular Imaging
por: Yi, Yong Weon, et al.
Publicado: (2020)

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors
por: Kang, Da Hyun, et al.
Publicado: (2020)

Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line
por: Kim, Seung Tae, et al.
Publicado: (2018)

Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas
por: Kim, Sewha, et al.
Publicado: (2019)

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma
por: Yoo, Changhoon, et al.
Publicado: (2020)

Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled Phase II Study
por: Jung, Hyun Ae, et al.
Publicado: (2022)

The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer
por: Zhao, Zheng, et al.
Publicado: (2021)

Characterization of Exosomes and Exosomal RNAs Isolated from Post-Mortem Body Fluids for Molecular Forensic Diagnosis
por: Kim, So-Yeon, et al.
Publicado: (2022)

Assessment of copy number in protooncogenes are predictive of poor survival in advanced gastric cancer
por: Li, Meihui, et al.
Publicado: (2021)

Comparative analysis of dietary exosome-derived microRNAs from human, bovine and caprine colostrum and mature milk
por: Yun, Bohyun, et al.
Publicado: (2021)

MDSC subtypes and CD39 expression on CD8(+) T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
por: Koh, Jiae, et al.
Publicado: (2020)

NIH3T3 Directs Memory-Fated CTL Programming and Represses High Expression of PD-1 on Antitumor CTLs
por: Qin, Yingyu, et al.
Publicado: (2019)

Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_39g9gl9nhn1qsdu58mavg90pa0